Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.
作者信息
Schneider Michael D
机构信息
Center for Cardiovascular Development, Baylor College of Medicine, One Baylor Plaza, Room 506D, Houston, TX 77030, USA.
出版信息
J Clin Invest. 2002 Mar;109(6):715-6. doi: 10.1172/JCI15292.
Abstract
摘要
相似文献
1
Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.
J Clin Invest. 2002 Mar;109(6):715-6. doi: 10.1172/JCI15292.
2
3
TGF-beta1 and angiotensin networking in cardiac remodeling.
Cardiovasc Res. 2004 Aug 15;63(3):423-32. doi: 10.1016/j.cardiores.2004.04.030.
4
Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.
J Mol Cell Cardiol. 1998 Aug;30(8):1559-69. doi: 10.1006/jmcc.1998.0721.
5
Myostatin, the cardiac chalone of insulin-like growth factor-1.
Cardiovasc Res. 2005 Dec 1;68(3):347-9. doi: 10.1016/j.cardiores.2005.09.007. Epub 2005 Oct 13.
6
B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
Clin Exp Pharmacol Physiol. 2010 Mar;37(3):283-9. doi: 10.1111/j.1440-1681.2009.05281.x. Epub 2009 Aug 28.
7
Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.
Eur J Pharmacol. 2009 Mar 15;606(1-3):115-20. doi: 10.1016/j.ejphar.2008.12.049. Epub 2009 Jan 15.
8
Insulin signaling: a possible pathogenesis of cardiac hypertrophy.
Cardiovasc Ther. 2010 Apr;28(2):101-5. doi: 10.1111/j.1755-5922.2009.00120.x.
9
Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts.
J Mol Cell Cardiol. 1997 Jul;29(7):1947-58. doi: 10.1006/jmcc.1997.0435.
10
Hypertension-mediated albuminuria is associated with reduced lysosomal activity in the kidney and the heart.
Am J Nephrol. 2009;29(5):454-64. doi: 10.1159/000176535. Epub 2008 Nov 21.
引用本文的文献
1
MicroRNA-144 regulates angiotensin II-induced cardiac fibroblast activation by targeting CREB.
Exp Ther Med. 2020 Sep;20(3):2113-2121. doi: 10.3892/etm.2020.8901. Epub 2020 Jun 17.
2
Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition.
J Cell Mol Med. 2020 Jul;24(14):8057-8068. doi: 10.1111/jcmm.15437. Epub 2020 May 28.
3
MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis.
J Am Heart Assoc. 2017 Nov 7;6(11):e006763. doi: 10.1161/JAHA.117.006763.
4
Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.
Mol Cell Biochem. 2017 Jan;424(1-2):123-145. doi: 10.1007/s11010-016-2849-0. Epub 2016 Oct 20.
5
MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis.
Circulation. 2016 Jan 19;133(3):291-301. doi: 10.1161/CIRCULATIONAHA.115.018174. Epub 2015 Nov 19.
6
Protective and Therapeutic Effects of Chinese Medicine Formula Jiajian Yunvjian on Experimental Cardiac Remodeling after Myocardial Infarction Induced by Coronary Artery Ligation.
Evid Based Complement Alternat Med. 2015;2015:949656. doi: 10.1155/2015/949656. Epub 2015 Jun 22.
7
TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.
J Immunol. 2009 Dec 1;183(11):7307-13. doi: 10.4049/jimmunol.0902736. Epub 2009 Nov 16.
本文引用的文献
1
TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.
J Clin Invest. 2002 Mar;109(6):787-96. doi: 10.1172/JCI14190.
2
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
Nat Med. 2002 Jan;8(1):35-40. doi: 10.1038/nm0102-35.
3
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
N Engl J Med. 2001 Dec 6;345(23):1667-75. doi: 10.1056/NEJMoa010713.
4
Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.
J Clin Invest. 2001 Dec;108(12):1843-51. doi: 10.1172/JCI13627.
5
Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
Kidney Int. 2001 Dec;60(6):2153-63. doi: 10.1046/j.1523-1755.2001.00067.x.
6
Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.
J Clin Invest. 2000 Aug;106(3):R25-9. doi: 10.1172/JCI10037.
7
Genetic dissection of cardiac growth control pathways.
Annu Rev Physiol. 2000;62:289-319. doi: 10.1146/annurev.physiol.62.1.289.
8
TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice.
Nat Med. 2000 May;6(5):556-63. doi: 10.1038/75037.
9
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.
Nature. 1999;402(6764):884-8. doi: 10.1038/47260.
10
Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts.
Cardiovasc Res. 1998 Nov;40(2):352-63. doi: 10.1016/s0008-6363(98)00121-7.
Zotero 插件